Jump to content

Search the Community

Showing results for tags 'derealisation'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Research - Actively Recruiting
    • Research Advertisements
  • Main Forums
    • PREPARATION FOR LIVESTREAMS
    • MAIN AND GENERAL FORUM
    • Introductions
    • Symptoms: Descriptions, Discussion, Debate
    • Medications & Other Treatments
  • Active and Future Research
    • Research Articles, Publications and Studies
  • Community Area
    • Community Open Space
    • Forum Information, Questions and Suggestions

Categories

There are no results to display.

There are no results to display.

Product Groups

There are no results to display.


Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


AIM


MSN


Website URL


ICQ


Yahoo


Jabber


Skype


Location


Interests


Administration Role

Found 3 results

  1. Abstract BACKGROUND: Following the hypothesis that blocking opioid receptors leads to a decline in opiate-modulated dissociative phenomena, experiences with naltrexone as medication for dissociative symptoms have been gained since 1999 (mainly in doses of 25-100 mg/day). PATIENTS AND METHODS: In this study patients with severe trauma-related and dissociative disorders were treated with naltrexone in doses of 2-6 mg/day (0.06 mg/kg body weight). RESULTS:The low dose treatment with naltrexone proved to be effective whereby 11 out of 15 patients reported immediate positive effects and 7 described a lasting helpful effect. The majority of patients who felt positive effects reported a clearer perception of both their surroundings and their inner life. Assessment of reality and dealing with it improved as did the perception of their own body and affects as well as self-regulation. The treatment was very low in side effects. CONCLUSION:Treatment with low-dose naltrexone may be a helpful element in the treatment of patients with complex posttraumatic stress disorder. However, it has to be realized that the decrease of dissociation may lead patients to a not yet resolvable challenge, in as much as dissociation had previously been a necessary mechanism of self-protection. PMID: 25421416 [PubMed - indexed for MEDLINE] Source: http://www.ncbi.nlm.nih.gov/pubmed/25421416 Originally found it here: https://ldnscience.org/research?filter_disease=70&filter_reported_as[0]=trial
  2. Hi, my name is Sander, I'm 16, from Amsterdam and I hope you can help me. I have derealisation, HPPD, slight psychosis, and slight depersonalisation. There once was a time I had ADD, PDD/NOS, psychosis, derealisation, depersonalisation, seratonin syndrome, Alice in Wonderland syndrome, and HPPD at the same time. My HPPD and derealisation were caused by weed but are still pretty heavy. My psychosis and depersonalisation were caused by by weed too but worsened by an overdose XTC. After that I got Alice in Wonderland syndrome and Seratonin syndrome which went away after about two months. Now I'm currently only bothered by slight depersonalisation and slight psychosis and severe HPPD. I am very sensitive to drugs. I overdosed at 300mg of XTC (Dutch XTC but the worst clean XTC you could get here). I can have a great trip on 75 miligrams (that's back when I only had PDD/NOS and ADD). I am going to a festival this summer and booze is very expensive there so the cheapest solution would be XTC. Now I have a source of very clean blue Tesla's with a high dosage of MDMA. Or I can get pure MDMA. My question is not if it's a smart idea to do this, (because it's really dumb) but how high the odds are that I can fall back into the mental diseases I had and how big the influences are on my current mental disorders. Thanks for reading
  3. anyone who got HPPD or Depersonalisation , got headaches as well ? i have derealization and visual snow, and i get terrible headaches, which seem to move around. thanks
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.